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In Germany, bluetongue disease had not been reported 
before 2006. During August 2006–August 2008, >24,000 
bluetongue virus serotype 8 infections were reported, most 
(20,635) in 2007. In 2006 and 2007, respectively, case-fa-
tality rates were 6.4% and 13.1% for cattle and 37.5% and 
41.5% for sheep. Vaccination in 2008 decreased cases.
B
luetongue disease (BT) is an infectious, but nonconta-
gious, viral infection of ruminants that is transmitted 
by Culicoides spp. biting midges. It can cause massive loss-
es in farmed ruminants, particularly sheep. BT had never 
been reported in Europe north of the Alps before August 
2006, when outbreaks almost simultaneously occurred in 
Belgium, France, Germany, and the Netherlands (1–4). We 
examined the epidemiology of this outbreak in Germany, 
where reporting of BT cases through the national animal 
disease notiﬁ  cation system (5) is mandatory. In this article, 
an outbreak is deﬁ  ned as the occurrence of BT in cattle, 
sheep, or goats on a farm involving at least 1 infected ani-
mal; a case is deﬁ  ned as a single infected animal. Wild ru-
minants infected with BT were always considered cases. 
The Study
In Germany, cattle were tested for BTV before trade 
or if disease was suspected from clinical signs. Diagnoses 
were made by serologic testing with commercial test kits 
(Pourquier ELISA Bluetongue Serum, Institut Pourquier, 
Montpellier, France; Bluetongue Virus Antibody Test 
Kit, VMRD, Pullman, WA, USA; ID Screen Blue Tongue 
Competition ELISA Kit, ID Vet, Montpellier, France; IN-
GEZIM BTV, INGENASA, Madrid, Spain) or real-time 
reverse transcription–PCR (RT-PCR) (6). 
Because no real-time RT-PCR for the sensitive detec-
tion of BTV serotype 8 (BTV-8) was available in Europe 
in 2006, we developed and validated such an assay. For the 
detection of BTV-8 genome, 0.8-μM primers (BTV8-NS1-
1F [5′-AAT GGG ATG TGT GTC AAA CAA AAT-3′]; 
BTV8-NS1-1R [5′-CAA CTA ATT TAT ACG CTT TCG 
CC-3′]) and a 0.2-μM probe (BTV8-NS1-1FAM [5′-FAM-
CTC CTC CGC ATC GGT CGC CGC-TAMRA-3′]) were 
used in a QuantiTect Probe RT-PCR kit (QIAGEN, Hilden, 
Germany). The method was then transferred to and imple-
mented at the regional laboratories of the German federal 
states responsible for BT screening; the results were con-
ﬁ  rmed by proﬁ  ciency testing. Since the summer of 2007, 
real-time RT-PCR assays for all known 24 serotypes of 
BTV (3) have also been used for BTV genome detection. 
Samples with inconclusive results in the differential pan-
BTV and BTV-8 tests were referred to the national refer-
ence laboratory, which conﬁ  rmed the exclusive presence 
of BTV-8 during the study period (August 2006–August 
2008).
In 2006, the disease was diagnosed on 571 cattle farms 
and in 309 sheep ﬂ  ocks, 3 other bovines, 6 red deer, 3 mou-
ﬂ  ons, and 1 roe deer in the federal states of North Rhine-
Westphalia, Rhineland-Palatinate, Hesse, Lower Saxony, 
and Saarland (Figure 1, panel A). The core region of the 
epidemic in Germany was in North Rhine-Westphalia, ad-
jacent to the affected areas in Belgium, the Netherlands, 
and Luxembourg. The disease was ﬁ  rst detected in late Au-
gust in calendar week 34 (37 cases), peaked mid October in 
calendar week 42 (154 cases), and decreased slowly until 
the end of the year (Figure 2). Apparently, the infection 
overwintered in the region (6) and ﬂ  ared up again in 2007, 
spreading over most of Germany during the summer and 
autumn of 2007 and resulting in 20,624 new outbreaks (Fig-
ure 1, panel B). During 2007, BT was detected on 12,638 
cattle farms and in 23 other individual bovines, 7,790 sheep 
ﬂ  ocks, 115 goat herds, 34 fallow deer, 11 mouﬂ  ons, 10 red 
deer, and 3 roe deer. The ﬁ  rst case of 2007 was detected 
in early June, calendar week 23. The number of new cases 
started to rise constantly from the end of July (week 30), 
peaked at 3,001 new cases in mid September (week 37), 
and subsequently decreased slowly until the end of year. 
The number of affected animals was higher for sheep in 
the ﬁ  rst months of the BT season in 2007; the number of 
affected cattle dominated the late phase (Figure 2).
In 2006, at least 48,364 cattle, 9,781 sheep, and 56 goats 
were exposed to BTV on affected premises (Table). Of 
these animals, 1,131 cattle (2.34%) and 590 sheep (6.03%) 
were found to be infected; 72 cattle and 221 sheep died. 
The case-fatality rate was much higher for sheep (37.5%) 
than for cattle (6.4%). These calculations are based on the 
assumption that all BT cases were reported. Because the 
infections caused only mild disease or remained even clini-
cally inapparent in some animals, especially cattle, under-
reporting is likely and the case-fatality rate in cattle may be 
slightly overestimated.
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population rose to at least 1,317,111 cattle, 503,282 sheep, 
and 3,346 goats on affected farms. The numbers of infected 
animals on these farms amounted to 26,772 cattle, 32,116 
sheep, and 209 goats in 20,624 new outbreaks. While mor-
tality rates remained relatively low, as in 2006, the case-
fatality proportion rose to 13.1% in cattle and 41.5% in 
sheep.
In 2008, BT incidence decreased considerably under 
the inﬂ  uence of a mass vaccination campaign that started 
in May and June 2008 (Figure 2), before the 2008 vector 
season. In 2008, a total of 1,070 new cases (PCR-positive, 
sampled after May 1, 2008; i.e., infection was acquired dur-
ing the current transmission season) were reported. They 
were found mainly in 2 regions in northwestern Lower 
Saxony and western Baden-Württemberg (Figure 1, panel 
C), where the vaccination campaign started relatively late 
because of an initially limited supply of BTV-8-vaccine.
Conclusions
The number of BTV-8 infections in Germany that 
peaked during the summer and autumn of 2007 showed that 
even a limited BTV-8 outbreak can dramatically spread 
within a few months after detection of the ﬁ  rst cases. Af-
ter the initial incursion and limited spread in 2006, BTV-8 
overwintered, resulting in efﬁ  cient spread of BTV-8 during 
2007 and severe consequences for cattle and sheep farm-
ers. The case-fatality rate was ≈3× higher for sheep than 
for cattle (37.5% vs. 6.4% in 2006 and 41.5% vs. 13.1% 
in 2007). These ﬁ  ndings illustrate that BTV-8 was more 
pathogenic for sheep than for cattle. It must be stressed, 
however, that the virus caused clinical disease and death in 
cattle, although other serotypes cause clinical disease and 
deaths primarily in sheep.
As a result of the vaccination campaign, the number 
of new cases reported in 2008 (through August 2008) was 
substantially lower than in 2007, demonstrating that conva-
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Figure 1. Maps showing outbreaks of bluetongue disease among all affected species in Germany in A) 2006, B) 2007, and C) 2008 



















Figure 2. Number of new cases/
outbreaks of bluetongue disease 
per calendar week in cattle 
(red), sheep (white), and goats 
(black), Germany.Bluetongue Virus Serotype 8, Germany
lescent animals are protected from reinfection and that vac-
cination was successful. In addition, restriction of animal 
movement from protection and surveillance zones appears 
reasonable, although the ability of restricted movement to 
decrease virus spread is limited, particularly during the 
vector season.
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Table. Animals affected by bluetongue virus serotype 8, Germany, 2006 and 2007  
Animals Total  no. animals  No. diseased animals No. deaths  Morbidity rate, %  Mortality rate, %  Case-fatality rate, % 
Cattle
 2006  48,364 1,131 72 2.34 0.15 6.37
 2007  1,317,111 26,772 3,512 2.03 0.27 13.12
Sheep
 2006  9,781 590 221 6.03 2.26 37.46
 2007  503,282 32,116 13,324 6.38 2.65 41.49
Goats
 2006  56 0 0 0 0 0
 2007  3,346 209 54 6.25 1.61 25.84
Use of trade names is for identiﬁ  cation only and does not imply 
endorsement by the Public Health Service or by the U.S. 
Department of Health and Human Services.